Form 4: Director Darryl L. Wilson Exercises Solventum RSUs

Solventum Corp Director Darryl L. Wilson acquired 3,403 shares of common stock through the vesting and settlement of restricted stock units.

Summary

• Director Darryl L. Wilson acquired 3,403 shares of Solventum Corp (SOLV) common stock on April 30, 2026.
• The acquisition resulted from the settlement of vested restricted stock units (RSUs).
• Following this transaction, the reporting person holds a total of 8,947 shares of common stock directly.
• The transaction involved no cash consideration, as the RSUs were settled at a price of $0 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard equity compensation vesting for a director.

Positives

• Increased equity stake by a member of the Board of Directors, signaling alignment with shareholder interests.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine disclosure of beneficial ownership changes.

Industry Context

StockSavvy.ai notes that routine RSU vesting for directors is a standard corporate governance practice and does not typically indicate a change in strategic direction or market outlook.

Comparison to Industry Standards

• The transaction is consistent with standard executive and director compensation packages in the healthcare and medical technology sectors.

Stakeholder Impact

• Minimal impact on shareholders as this represents the fulfillment of existing compensation agreements.

Key Dates

Keywords

Solventum, SOLV, Form 4, Insider Trading, Director, Restricted Stock Units